Guideline

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.2, 2013, Pages

  Abramowicz, Daniel ^a   Cochat, Pierre ^b   Claas, Frans ^c,d   Dudley, Chris ^e   Harden, Paul ^f   Heeman, Uwe ^g   Hourmant, Maryvonne ^h   Maggiore, Umberto ⁱ   Pascual, Julio ^j   Salvadori, Maurizio ^k   Spasovski, Goce ^l   Squifflet, Jean Paul ^m   Steiger, Juerg ⁿ   Torres, Armando ^o   Vanholder, Raymond ^p   Van Biesen, Wim ^p   Viklicky, Ondrej ^q   Zeier, Martin ^r   Nagler, Evi ^p  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LYON 1   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Eurotransplant Reference Laboratory   (Netherlands)

^e SOUTHMEAD HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF PARMA   (Italy)

^j INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l Skopje University Hospital   (Macedonia)

^m UNIVERSITY OF LIÈGE   (Belgium)

ⁿ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^o UNIVERSIDAD DE LA LAGUNA   (Spain)

^p GHENT UNIVERSITY HOSPITAL   (Belgium)

^q INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^r UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; TOBACCO SMOKE; VARICELLA ZOSTER VACCINE;

AGE; ALCOHOL ABUSE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CLINICAL DECISION MAKING; DRUG ABUSE; EVIDENCE BASED MEDICINE; EXPERIMENTAL DESIGN; FOCAL GLOMERULOSCLEROSIS; FUNDING; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HEMATURIA; HEMOLYTIC UREMIC SYNDROME; HERPES ZOSTER; HLA MATCHING; HLA TYPING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MEDICAL HISTORY; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL SERVICE; MEDICAL SOCIETY; NEPHRECTOMY; OBESITY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PROTEINURIA; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; SECONDARY HYPERPARATHYROIDISM; SMOKING; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 84884577042     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft218     Document Type: Review

References (436)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9:s1-s157
2. Heemann U, Abramowicz D, Spasovski G, Vanholder R. European Renal Best Practice Work Group on Kidney Transplantation. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transpl 2011;26:2099-2106
3. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997;127:380-387 (Pubitemid 27362747)
4. Shea BJ, Grimshaw JM, Wells GA et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10
5. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. The Cochrane Collaboration, 2008
6. Wells GA, Shea BJ, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. Retrieved from: www.ohri.ca/programs/clinical-epidemiology/oxford.asp
7. Guyatt GH, Oxman AD, Kunz R et al. Going from evidence to recommendations. Br Med J 2008;336:1049-1051
8. Balshem H, Helfand M, Schunemann HJ et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-406
9. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913 (Pubitemid 38745589)
10. Kessler M, Jay N, Molle R, Guillemin F. Excess risk of cancer in renal transplant patients. Transpl Int 2006;19:908-914 (Pubitemid 44511115)
11. Vajdic CM, McDonald SP, McCredie MR et al. Cancer incidence before and after kidney transplantation. JAMA 2006;296:2823-2831 (Pubitemid 44969182)
12. Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15, 183 recipients. Am J Transplant 2007;7:2140-2151 (Pubitemid 47247055)
13. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007;7:941-948 (Pubitemid 46481211)
14. Stewart JH, Vajdic CM, van Leeuwen MT et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transpl 2009;24:3225-3231
15. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology 1997;50:525-528 (Pubitemid 27433210)
16. Gulanikar AC, Daily PP, Kilambi NK, Hamrick-Turner JE, Butkus DE. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation 1998;66:1669-1672 (Pubitemid 29034989)
17. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: an International Collaborative Study. Lancet 1999;354:93-99 (Pubitemid 29313142)
18. Fischereder M, Jauch KW. Prevalence of cancer history prior to renal transplantation. Transpl Int 2005;18:779-784 (Pubitemid 41726806)
19. Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2007;2:750-756
20. Lemy A, Wissing KM, Rorive S et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year followup. Am J Kidney Dis 2008;51:471-477 (Pubitemid 351273477)
21. Klatte T, Seitz C, Waldert M et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int 2010;105:1260-1265
22. Veroux M, Giuffrida G, Gagliano M et al. Evaluation of thyroid disease in kidney transplantation candidates: management and follow-up. Transplant Proc 2009;41:1142-1144
23. Karamchandani D, Arias-Amaya R, Donaldson N, Gilbert J, Schulte KM. Thyroid cancer and renal transplantation: a metaanalysis. Endocr-Relat Cancer 2010;17:159-167
24. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998;147-158
25. Chapman JR, Sheil AG, Disney AP. Recurrence of cancer after renal transplantation. Transplant Proc 2001;33:1830-1831 (Pubitemid 32238082)
26. Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 1997;2:14-17
27. Mulley W. The KHA-CARI Guidelines. Recipient assessment for transplantation: Malignancy. KHA-CARI; 2011. Retrieved from: http://www.cari.org.au/TRANS-recipient-assessment/Malignancy-31-Aug-2011.pdf
28. Dudley C, Harden P. Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient. Nephron Clin Pract 2011:118s-s224
29. Karam G, Kälbe T, Alcarez A et al. Guidelines on Renal Transplantation. The European Association of Urology; 2009. Retrieved from: http://www.uroweb.org/gls/pdf/26-Renal-Transplant-LR.pdf
30. Trullas JC, Cofan F, Tuset M et al. Renal transplantation in HIV-infected patients: 2010 update. Kidney Int 2011;79:825-843
31. EBPG Expert Group on Renal Transplantation. I.4 Contraindications for transplantation. Nephrol Dial Transpl 2000;15:5-6
32. Swanson SJ, Kirk AD, Ko CW, Jones CA, Agodoa LY, Abbott KC. Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. Tranplant Infect Dis 2002;4:144-147 (Pubitemid 35364778)
33. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004;15:1633-1639 (Pubitemid 38679689)
34. Gruber SA, Doshi MD, Cincotta E et al. Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates. Transplantation 2008;86:269-274
35. Kumar MS, Sierka DR, Damask AM et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005;67:1622-1629 (Pubitemid 40463144)
36. Landin L, Rodriguez-Perez JC, Garcia-Bello MA et al. Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series. Nephrol Dial Transpl 2010;25:3106-3115
37. Locke JE, Montgomery RA, Warren DS, Subramanian A, Segev DL. Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg 2009;144:83-86
38. Mazuecos A, Fernandez A, Andres A et al. HIV infection and renal transplantation. Nephrol Dial Transpl 2011;26:7
39. Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation 2006;81:1658-1661 (Pubitemid 43948298)
40. Roland ME. Solid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy era. Top HIV Med 2004;12:73-76
41. Stock PG, Barin B, Murphy B et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010;363:2004-2014
42. Touzot M, Pillebout E, Matignon M et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant 2010;10:2263-2269
43. Tricot L, Teicher E, Peytavin G et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009;9:1946-1952
44. Yoon SC, Hurst FP, Jindal RM et al. Trends in renal transplantation in patients with human immunodeficiency virus infection: an analysis of the United States renal data system. Transplantation 2011;91:5
45. Gracey D. The CARI Guidelines. Recipient assessment for transplantation: HIV, HBV and HCV infection. 2011. DOI:
46. Furth SL, Hogg RJ, Tarver J et al. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 2003;18:33-38 (Pubitemid 36798470)
47. Crespo JF, Gorriz JL, Avila A et al. Prevalence of past varicella zoster virus infection in candidates for kidney transplantation: vaccination in seronegative patients. Transplant Proc 2002;34:77 (Pubitemid 34311577)
48. Geel AL, Landman TS, Kal JA, van Doomum GJ, Weimar W. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc 2006;38:3418-3419 (Pubitemid 44908474)
49. Giacchino R, Marcellini M, Timitilli A et al. Varicella vaccine in children requiring renal or hepatic transplantation. Transplantation 1995;60:1055-1056
50. Webb NJ, Fitzpatrick MM, Hughes DA et al. Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child 2000;82:141-143 (Pubitemid 30305709)
51. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: longterm results of vaccination. Pediatrics 1997;99:35-39 (Pubitemid 27136599)
52. Kitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis 1993;17:441-447 (Pubitemid 23261461)
53. Olson AD, Shope TC, Flynn JT. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation. Pediatr Transplant 2001;5:44-50 (Pubitemid 32179002)
54. Chadban SJ, Barraclough KA, Campbell SB et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology 2012;17:204-214
55. Artz MA, Steenbergen EJ, Hoitsma AJ, Monnens LAH, Wetzels JFM. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation 2003;76:821-826 (Pubitemid 37140227)
56. Ferraris JR, Ramirez JA, Ruiz S et al. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation. Pediatr Nephrol 2002;17:809-814 (Pubitemid 36097369)
57. Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003;18:1095-1101 (Pubitemid 37406854)
58. Bresin E, Daina E, Noris M et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 2006;1:88-99
59. Noris M, Caprioli J, Bresin E et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010;5:1844-1859
60. Lahlou A, Lang P, Charpentier B et al. Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF). Medicine 2000;79:90-102 (Pubitemid 30205510)
61. Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 2011;7:23-35
62. Andrews PA, Burnapp L, Manas D et al. Summary of the British Transplantation Society/Renal Association U. K. guidelines for living donor kidney transplantation. Transplantation 2012;93:666-673
63. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002;347:103-109 (Pubitemid 34753480)
64. Canaud G, Dion D, Zuber J et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transpl 2009;25:1321-1328
65. Cara-Fuentes GM, Meseguer CG, Carrion AP et al. Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol 2010;25:529-534
66. Hickson LJ, Gera M, Amer H et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 2009;87:1232-1239
67. Jungraithmayr TC, Bulla M, Dippell J et al. Primary focal segmental glomerulosclerosis-long-term outcome after pediatric renal transplantation. Pediatr Transplant 2005;9:226-231 (Pubitemid 40476853)
68. Pardon A, Audard V, Caillard S et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transpl 2006;21:1053-1059
69. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001;59:328-333 (Pubitemid 32055241)
70. Moroni G, Gallelli B, Quaglini S, Banfi G, Montagnino G, Messa P. Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transpl Int 2010;23:208-216
71. Ruf RG, Lichtenberger A, Karle SM et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004;15:722-732 (Pubitemid 38294803)
72. Anderson P, Gual A, Colom J. Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Barcelona: Department of Health of the Government of Catalonia, 2005
73. Fierz K, Steiger J, Denhaerynck K, Dobbels F, Bock A, De Geest S. Prevalence, severity and correlates of alcohol use in adult renal transplant recipients. Clin Transplant 2006;20:171-178
74. Gueye AS, Chelamcharla M, Baird BC et al. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol Dial Transpl 2007;22:891-898 (Pubitemid 46351702)
75. John D, Callender CO, Flores J et al. Renal transplantation in substance abusers revisited: the Howard University Hospital experience. Transplant Proc 1989;21:1422-1424 (Pubitemid 19130893)
76. Cho S, Toledo-Pereyra LH, Whitten JI, Mittal V, Allaben R. Kidney transplantation in drug-addicts. Bol Asoc Med P R 1985;77:136-137
77. Gordon MJ, White R, Matas AJ et al. Renal transplantation in patients with a history of heroin abuse. Transplantation 1986;42:556-557 (Pubitemid 17196084)
78. [Erratum appears in Transplantation 1987 Mar; 43(3):459]
79. Aker S, Ivens K, Grabensee B, Heering P. Cardiovascular risk factors and diseases after renal transplantation. Int Urol Nephrol 1998;30:777-788 (Pubitemid 29125544)
80. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transpl 1997;12:1672-1679 (Pubitemid 27346295)
81. Aull-Watschinger S, Konstantin H, Demetriou D et al. Pretransplant predictors of cerebrovascular events after kidney transplantation. Nephrol Dial Transpl 2008;23:1429-1435 (Pubitemid 351767492)
82. Cardinal H, Hebert MJ, Rahme E et al. Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney Int 2005;68:345-351 (Pubitemid 43181394)
83. Chuang P, Gibney EM, Chan L, Ho PM, Parikh CR. Predictors of cardiovascular events and associated mortality within two years of kidney transplantation. Transplant Proc 2004;36:1387-1391 (Pubitemid 38902984)
84. Cosio FG, Alamir A, Yim S et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998;53:767-772 (Pubitemid 28124294)
85. de Mattos AM, Prather J, Olyaei AJ et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 2006;70:757-764 (Pubitemid 44215352)
86. Doyle SE, Matas AJ, Gillingham K, Rosenberg ME. Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int 2000;57:2144-2150 (Pubitemid 30252309)
87. Fellstrom B, Holdaas H, Jardine AG et al. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 2005;79:205-212
88. Feyssa E, Jones-Burton C, Ellison G, Philosophe B, Howell C. Racial/ethnic disparity in kidney transplantation outcomes: influence of donor and recipient characteristics. J Natl Med Assoc 2009;101:111-115
89. Gordon EJ, Prohaska TR, Gallant MP et al. Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipients. Transpl Int 2009;22:990-998
90. Hernandez D, Hanson E, Kasiske MK, Danielson B, Roel J, Kasiske BL. Cytomegalovirus disease is not a major risk factor for ischemic heart disease after renal transplantation. Transplantation 2001;72:1395-1399 (Pubitemid 33015765)
91. Humar A, Kerr SR, Ramcharan T, Gillingham KJ, Matas AJ. Peri-operative cardiac morbidity in kidney transplant recipients: incidence and risk factors. Clin Transplant 2001;15:154-158 (Pubitemid 32487440)
92. Israni AK, Snyder JJ, Skeans MA et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant 2010;10:338-353
93. Jardine AG, Fellstrom B, Logan JO et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 2005;46:529-536 (Pubitemid 41208190)
94. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001:72S-S8
95. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000;11:1735-1743
96. Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 2000;11:753-759 (Pubitemid 30171885)
97. Lentine KL, Rocca Rey LA, Kolli S et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol 2008;3:1090-1101
98. Lentine KL, Schnitzler MA, Abbott KC et al. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis 2005;46:720-733 (Pubitemid 41383951)
99. Marcen R, Morales JM, Arias M et al. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. J Am Soc Nephrol 2006:17S-S290
100. Matas AJ, Payne WD, Sutherland DE et al. 2, 500 living donor kidney transplants: a single-center experience. Ann Surg 2001;234:149-164 (Pubitemid 32729421)
101. Mohamed Ali AA, Abraham G, Mathew M et al. Can serial eGFR, body mass index and smoking predict renal allograft survival in south Asian patients. Saudi J Kidney Dis Transpl 2009;20:984-990
102. Nankivell BJ, Lau SG, Chapman JR, O'Connell PJ, Fletcher JP, Allen RD. Progression of macrovascular disease after transplantation. Transplantation 2000;69:574-581 (Pubitemid 30129592)
103. Nogueira JM, Haririan A, Jacobs SC, Cooper M, Weir MR. Cigarette smoking, kidney function, and mortality after live donor kidney transplant. Am J Kidney Dis 2010;55:907-915
104. Oschatz E, Benesch T, Kodras K, Hoffmann U, Haas M. Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 2006;48:307-313 (Pubitemid 44069606)
105. Ozdemir FN, Karakan S, Akgul A, Haberal M. Metabolic syndrome is related to long-term graft function in renal transplant recipients. Transplant Proc 2009;41:2808-2810
106. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002;62:1848-1854 (Pubitemid 35286295)
107. Siedlecki A, Foushee M, Curtis JJ et al. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation 2007;84:1610-1617
108. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM. Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 2001;71:1752-1757 (Pubitemid 32622486)
109. Valdes-Canedo F, Pita-Fernandez S, Seijo-Bestilleiro R et al. Incidence of cardiovascular events in renal transplant recipients and clinical relevance of modifiable variables. Transplant Proc 2007;39:2239-2241 (Pubitemid 47418123)
110. Yango AF, Gohh RY, Monaco AP et al. Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacity. Clin Nephrol 2006;65:401-407 (Pubitemid 43853528)
111. Bosma RJ, Kwakernaak AJ, van der Heide JJ, de Jong PE, Navis GJ. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am J Transplant 2007;7:645-652 (Pubitemid 46376455)
112. Bumgardner GL, Henry ML, Elkhammas E et al. Obesity as a risk factor after combined pancreas/kidney transplantation. Transplantation 1995;60:1426-1430 (Pubitemid 26012675)
113. Burroughs TE, Swindle J, Takemoto S et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007;83:1027-1034 (Pubitemid 46659113)
114. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007;84:981-987 (Pubitemid 350287379)
115. Cheung CY, Chan YH, Chan HW, Chau KF, Li CS. Optimal body mass index that can predict long-term graft outcome in Asian renal transplant recipients. Nephrology 2010;15:259-265
116. el Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004;77:1381-1385 (Pubitemid 38668431)
117. Gore JL, Pham PT, Danovitch GM et al. Obesity and outcome following renal transplantation. Am J Transplant 2006;6:357-363 (Pubitemid 43382172)
118. Hoogeveen EK, Aalten J, Rothman KJ et al. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation 2011;91:869-874
119. Johnson DW, Isbel NM, Brown AM et al. The effect of obesity on renal transplant outcomes. Transplantation 2002;74:675-681
120. Kovesdy CP, Czira ME, Rudas A et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010;10:2644-2651
121. Lentine KL, Xiao H, Brennan DC et al. The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J 2009;158:972-982
122. Meier-Kriesche H-U, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73:70-74 (Pubitemid 34094688)
123. Papalia T, Greco R, Lofaro D, Maestripieri S, Mancuso D, Bonofiglio R. Impact of body mass index on graft loss in normal and overweight patients: retrospective analysis of 206 renal transplants. Clin Transplant 2010:24E-E246
124. Drafts HH, Anjum MR, Wynn JJ, Mulloy LL, Bowley JN, Humphries AL. The impact of pre-transplant obesity on renal transplant outcomes. Clin Transplant 1997;11:493-496 (Pubitemid 27460509)
125. Glanton CW, Kao TC, Cruess D, Agodoa LY, Abbott KC. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003;63:647-653 (Pubitemid 36126811)
126. Torres A, Rodriguez AP, Concepcion MT et al. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transpl 1998:13s-s97
127. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004;19:1281-1287 (Pubitemid 38628152)
128. Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007;21:558-566 (Pubitemid 47177046)
129. Gwinner W, Suppa S, Mengel M et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 2005;5:1934-1941 (Pubitemid 41039868)
130. Roodnat JI, van Gurp EA, Mulder PG et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation 2006;82:362-367 (Pubitemid 44223035)
131. Kandil E, Florman S, Alabbas H et al. Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci 2010;339:420-424
132. Chou FF, Hsieh KC, Chen YT, Lee CT. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Transplantation 2008;86:554-557
133. Bubenicek P, Sotornik I, Vitko S, Teplan V. Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study. Kidney Blood Press Res 2008;31:196-202 (Pubitemid 351915047)
134. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009:76s-s130
135. Goldsmith DJA, Covic A, Fouque D et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transpl 2010;25:3823-3832
136. Evenepoel P, Sprangers B, Lerut E et al. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin Transplant 2012;26:393-402
137. Ali M, Giblin L, Farhad K et al. Pretransplant cardiac investigations in the Irish renal transplant population-the effectiveness of our current screening techniques in predicting cardiac events. Ren Fail 2004;26:375-380 (Pubitemid 39167613)
138. Eschertzhuber S, Hohlrieder M, Boesmueller C et al. Incidence of coronary heart disease and cardiac events in patients undergoing kidney and pancreatic transplantation. Transplant Proc 2005;37:1297-1300 (Pubitemid 40590869)
139. Lin K, Stewart D, Cooper S, Davis CL. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 2001;15:269-275 (Pubitemid 32725411)
140. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005;80:815-820 (Pubitemid 41443765)
141. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002
142. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993;44:617-621 (Pubitemid 23265232)
143. Manske CL, Wilson RF, Wang Y, Thomas W. Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 1997;29:601-607 (Pubitemid 27155283)
144. De Lima JJ, Gowdak LH, de Paula FJ et al. Treatment of coronary artery disease in hemodialysis patients evaluated for transplant-a registry study. Transplantation 2010;89:845-850
145. Jeloka TK, Ross H, Smith R et al. Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant 2007;21:609-614 (Pubitemid 47399424)
146. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transpl 1997;12:1187-1191 (Pubitemid 27230555)
147. Barrionuevo JD, Vargas-Machuca MF, Pulido FG, Sacaluga LG, Govantes MA, Martinez MA. Prevalence of cardiovascular disease in kidney transplant candidates: outpatient cardiac evaluation. Transplant Proc 2010;42:3126-3127
148. Charytan D, Kuntz RE, Mauri L, DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007;49:409-416
149. Wang LW, Fahim MA, Hayen A et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Am J Kidney Dis 2011;57:476-487
150. Patel AD, Abo-Auda WS, Davis JM et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003;92:146-151 (Pubitemid 36835962)
151. Reis G, Marcovitz PA, Leichtman AB et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995;75:707-710
152. West JC, Napoliello DA, Costello JM et al. Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transpl Int 2000:13s-s30
153. Venkataraman R, Hage FG, Dorfman T et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol 2008;102:1451-1456
154. Hage FG, Smalheiser S, Zoghbi GJ et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol 2007;100:1020-1025 (Pubitemid 47368111)
155. Patel RK, Mark PB, Johnston N et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant 2008;8:1673-1683
156. Sharma R, Chemla E, Tome M et al. Echocardiography-based score to predict outcome after renal transplantation. Heart 2007;93:464-469 (Pubitemid 46631512)
157. Jones DG, Taylor AM, Enkiri SA et al. Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant 2009;9:1846-1852
158. Lee J. Live kidney donor assessment in the UK and Ireland. Br J Surg 1999;86:1588
159. Drognitz O, Kirste G, Schramm I et al. Kidney transplantation with concomitant unilateral nephrectomy: a matched-pair analysis on complications and outcome. Transplantation 2006;81:874-880
160. Erturk E, Burzon DT, Orloff M, Rabinowitz R. Outcome of patients with vesicoureteral reflux after renal transplantation: the effect of pretransplantation surgery on posttransplant urinary tract infections. Urology 1998;51:27-30 (Pubitemid 28267875)
161. Fuller TF, Brennan TV, Feng S, Kang S-M, Stock PG, Freise CE. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol 2005;174:2284-2288 (Pubitemid 41611804)
162. Glassman DT, Nipkow L, Bartlett ST, Jacobs SC. Bilateral nephrectomy with concomitant renal graft transplantation forautosomal dominant polycystic kidney disease. J Urol 2000;164:661-664 (Pubitemid 30637597)
163. Kirkman MA, van Dellen D, Mehra S et al. Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? BJU Int 2011;108:590-594
164. Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P. Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation. Nephrol Dial Transpl 1996;11:2045-2049 (Pubitemid 26345471)
165. Rozanski J, Kozlowska I, Myslak M et al. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc 2005;37:666-668 (Pubitemid 40590664)
166. Salehipour M, Jalaeian H, Salahi H et al. Are large nonfunctional kidneys risk factors for posttransplantation urinary tract infection in patients with end-stage renal disease due to autosomal dominant polycystic kidney disease? Transplant Proc 2007;39:887-888 (Pubitemid 46764854)
167. Sanfilippo F, Vaughn WK, Spees EK. The association of pretransplant native nephrectomy with decreased renal allograft rejection. Transplantation 1984;37:256-260
168. Sulikowski T, Tejchman K, Zietek Z et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc 2009;41:177-180
169. Tabibi A, Simforoosh N, Abadpour P, Gholamrezaie HR, Nafar M. Concomitant nephrectomy of massively enlarged kidneys and renal transplantation in autosomal dominant polycystic kidney disease. Transplant Proc 2005;37:2939-2940 (Pubitemid 41435580)
170. Wagner MD, Prather JC, Barry JM. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease. J Urol 2007;177:2250-2254 (Pubitemid 46726412)
171. Bryan CF, Harrell KM, Nelson PW et al. HLA-DR and DQ typing by polymerase chain reaction using sequencespecific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serology. Transplantation 1996;62:1819-1824
172. Mytilineos J, Scherer S, Dunckley H et al. DNA HLA-DR typing results of 4000 kidney transplants. Transplantation 1993;55:778-781 (Pubitemid 23122046)
173. * incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations. Transplantation 1997;64:612-616 (Pubitemid 27377194)
174. Mytilineos J, Scherer S, Opelz G. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals. Transplantation 1990;50:870-873
175. Mytilineos J, Lempert M, Middleton D et al. HLA class I DNA typing of 215 'HLA-A, -B, -DR zero mismatched' kidney transplants. Tissue Antigens 1997;50:355-358 (Pubitemid 27405877)
176. Opelz G. HLA matching in Asian recipients of kidney grafts from unrelated living or cadaveric donors. The Collaborative Transplant Study. Hum Immunol 2000;61:115-119 (Pubitemid 30075232)
177. Laux G, Opelz G Immunological relevance of CREG matching in cadaver kidney transplantation. Transplantation 2004;78:442-446 (Pubitemid 39095412)
178. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009;88:23-29
179. McKenna RM, Lee KR, Gough JC et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation 1998;66:38-43 (Pubitemid 28341165)
180. Bryan CF, Harrell KM, Mitchell SI et al. HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant 2003;3:459-464 (Pubitemid 36560098)
181. Ichikawa Y, Hashimoto M, Nojima M et al. The significant effect of HLA-DRB1 matching on long-term kidney graft outcome. Transplantation 1993;56:1368-1371 (Pubitemid 24018787)
182. Meier-Kriesche HU, Ojo AO, Leichtman AB et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 2001;71:398-401 (Pubitemid 32175975)
183. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E. The role of HLA matching in renal transplantation: experience from one center. Rev Immunogenet 1999;1:343-350
184. Terasaki PI. The HLA-matching effect in different cohorts of kidney transplant recipients. Clin Transpl 2000;497-514
185. Frohn C, Fricke L, Puchta JC, Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transpl 2001;16:355-360 (Pubitemid 32123926)
186. Hata Y, Cecka JM, Takemoto S, Ozawa M, Cho YW, Terasaki PI. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation 1998;65:208-212 (Pubitemid 28099213)
187. Edwards EB, Bennett LE, Cecka JM. Effect of HLA matching on the relative risk of mortality for kidney recipients: a comparison of the mortality risk after transplant to the mortality risk of remaining on the waiting list. Transplantation 1997;64:1274-1277 (Pubitemid 27495959)
188. Egfjord M, Jakobsen BK, Ladefoged J. No impact of crossreactive group human leucocyte antigen class I matching on long-term kidney graft survival. Scand J Immunol 2003;57:362-365 (Pubitemid 36408207)
189. Kerman RH, Kimball PM, Lindholm A et al. Influence of HLA matching on rejections and short-and long-term primary cadaveric allograft survival. Transplantation 1993;56:1242-1247 (Pubitemid 23348709)
190. Cecka JM. Kidney transplantation in the United States. Clin Transpl 2008;1-18
191. Opelz G, Dohler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 2010;90:292-297
192. Opelz G, Dohler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007;84:137-143 (Pubitemid 47205745)
193. Doxiadis IIN, de Fijter JW, Mallat MJK et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 2007;83:1207-1213 (Pubitemid 46743682)
194. Tran TH, Dohler B, Heinold A, Scherer S, Ruhenstroth A, Opelz G. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation 2011;92:419-425
195. Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM. HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010;75:278-285
196. Qiu J, Cai J, Terasaki PI, El-Awar N, Lee JH. Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. Transplantation 2005;80:1511-1513 (Pubitemid 41803635)
197. Mytilineos J, Deufel A, Opelz G. Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study. Transplantation 1997;63:1351-1354 (Pubitemid 27212833)
198. Laux G, Mansmann U, Deufel A, Opelz G, Mytilineos J. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants. Transplantation 2003;75:1527-1532 (Pubitemid 36597290)
199. Mizutani K, Terasaki P, Bignon JD et al. Association of kidney transplant failure and antibodies against MICA. Hum Immunol 2006;67:683-691 (Pubitemid 44430109)
200. Panigrahi A, Gupta N, Siddiqui JA et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol 2007;68:362-367 (Pubitemid 46616976)
201. Zou Y, Heinemann FM, Grosse-Wilde H et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 2006;67:230-237 (Pubitemid 43673927)
202. Li L, Chen A, Chaudhuri A et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010;89:312-319
203. Zou Y, Stastny P, sal C, hler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007;357:1293-1300 (Pubitemid 47481451)
204. Lemy A, Andrien M, Wissing KM et al. Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes. Transplantation 2010;90:168-174
205. Gratwohl A, Dohler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 2008;372:49-53 (Pubitemid 351902262)
206. Kim SJ, Gill JS. H-Y incompatibility predicts short-term outcomes for kidney transplant recipients. J Am Soc Nephrol 2009;20:2025-2033
207. Tan JC, Wadia PP, Coram M et al. H-Y antibody development associates with acute rejection in female patients with male kidney transplants. Transplantation 2008;86:75-81
208. van Bergen J, Thompson A, Haasnoot GW et al. KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant 2011;11:1959-1964
209. Kunert K, Seiler M, Mashreghi MF et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007;84:1527-1533 (Pubitemid 350294729)
210. Le Bas-Bernardet S, Hourmant M, Coupel S, Bignon JD, Soulillou JP, Charreau B. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003;3:167-177 (Pubitemid 36323114)
211. Dragun D, ller DN, sen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005;352:558-569 (Pubitemid 40204669)
212. Amico P, Honger G, Bielmann D et al. Incidence and prediction of early antibody-mediated rejection due to nonhuman leukocyte antigen-antibodies. Transplantation 2008;85:1557-1563
213. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007;7:1808-1814 (Pubitemid 46905444)
214. Aguilera I, varez-Marquez A, Gentil MA et al. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients. Nephrol Dial Transplant 2008;23:2393-2398 (Pubitemid 351957595)
215. Alvarez M, Aguilera I, Gentil MA et al. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Transplantation 2009;87:94-99
216. Claas FH, Rahmel A, Doxiadis II. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program (Review). Transplantation 2009;88:447-452
217. Montgomery RA, Lonze BE, Jackson AM. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Curr Opin Organ Tran 2011;16:439-444
218. Morath C, Beimler J, Opelz G et al. An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 2010;90:645-653
219. Marfo K, Lu A, Ling M, Akalin E. Desensitization protocols and their outcome. Clin J Am Soc Nephrol 2011;6:922-936
220. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002;2:758-760 (Pubitemid 36342618)
221. Montgomery RA, Lonze BE, King KE et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011;365:318-326
222. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006;6:346-351 (Pubitemid 43382170)
223. Bartel G, Wahrmann M, Regele H et al. Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Am J Transplant 2010;10:2033-2042
224. Vo AA, Peng A, Toyoda M et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation 2010;89:1095-1102
225. Loupy A, Suberbielle-Boissel C, Zuber J et al. Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study. Transplantation 2010;89:1403-1410
226. Perry DK, Burns JM, Pollinger HS et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 2009;9:201-209
227. Stegall MD, Diwan T, Raghavaiah S et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011;11:2405-2413
228. Douzdjian V, Rice JC, Carson RW, Gugliuzza KK, Fish JC. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome. Clin Transplant 1996;10:203-208 (Pubitemid 26091834)
229. Fernandez AT, Minana LB, Polo VG et al. Impact of transplantectomy of the first graft on the clinical course of cadaver renal retransplantation. Actas Urol Esp 1999;23:864-872 (Spanish)
230. Abouljoud MS, Deierhoi MH, Hudson SL, Diethelm AG. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995;60:138-144
231. Schleicher C, Wolters H, Kebschull L et al. Impact of failed allograft nephrectomy on initial function and graft survival after kidney retransplantation. Transpl Int 2011;24:284-291
232. Sumrani N, Delaney V, Hong JH, Daskalakis P, Sommer BG. The influence of nephrectomy of the primary allograft on retransplant graft outcome in the cyclosporine era. Transplantation 1992;53:52-55
233. Marrari M, Duquesnoy RJ. Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transpl Immunol 2010;22:105-109
234. Yagmurdur MC, Emiroglu R, Ayvaz I, Sozen H, Karakayali H, Haberal M. The effect of graft nephrectomy on long-term graft function and survival in kidney retransplantation. Transplant Proc 2005;37:2957-2961 (Pubitemid 41435586)
235. Ahmad N, Ahmed K, Mamode N. Does nephrectomy of failed allograft influence graft survival after re-transplantation? Nephrol Dial Transpl 2009;24:639-642
236. Johnston O, Rose C, Landsberg D, Gourlay WA, Gill JS. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007;7:1961-1967 (Pubitemid 47037994)
237. Ayus JC, Achinger SG, Lee S, Sayegh MH, Go AS. Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol 2010;21:374-380
238. Del Bello A, Congy N, Sallusto F et al. Anti-human leukocyte antigen immunization after early allograft nephrectomy. Transplantation 2012;93:936-941
239. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2:662-665
240. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969;280:735-739
241. Noreen HJ, McKinley DM, Gillingham KJ, Matas AJ, Segall M. Positive remote crossmatch: impact on short-term and longterm outcome in cadaver renal transplantation. Transplantation 2003;75:501-505 (Pubitemid 36241147)
242. Baron C, Pastural M, Lang P et al. Long-term kidney graft survival across a positive historic but negative current sensitized cross-match. Transplantation 2002;73:232-236 (Pubitemid 34112846)
243. Praticò-Barbato L, Conca R, Magistroni P et al. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome. Transpl Immunol 2008;19:238-243
244. Le Bas-Bernardet S, Hourmant M, Valentin N et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003;75:477-482 (Pubitemid 36241142)
245. Eng HS, Bennett G, Tsiopelas E et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008;8:2335-2342
246. Bryan CF, Baier KA, Nelson PW et al. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation 1998;66:1827-1832 (Pubitemid 29035015)
247. Couzi L, Araujo C, Guidicelli G et al. Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay. Transplantation 2011;91:527-535
248. Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001;12:2807-2814 (Pubitemid 33115429)
249. Lindemann M, Nyadu B, Heinemann FM et al. High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation. Hum Immunol 2010;71:771-776
250. Christiaans MH, Overhof R, ten HA, Nieman F, van Hooff JP, van den Berg-Loonen EM. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996;62:1341-1347 (Pubitemid 27008565)
251. Kerman RH, Susskind B, Buyse I et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 1999;68:1855-1858 (Pubitemid 30027337)
252. Opelz G, hler B, sal C. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol 2009;70:627-630
253. Bryan CF, McDonald SB, Luger AM et al. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis. Clin Transplant 2006;20:563-570 (Pubitemid 44383401)
254. Lobo PI, Isaacs RB, Spencer CE et al. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation. Transpl Int 2002;15:563-569 (Pubitemid 36061729)
255. Vaidya S, Cooper TY, Avandsalehi J et al. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Transplantation 2001;71:422-428 (Pubitemid 32175980)
256. Billen EV, Christiaans MH, van den Berg-Loonen EM. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens 2009;74:205-212
257. Breimer ME, Rydberg L, Jackson AM et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009;87:549-556
258. Bielmann D, nger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007;7:626-632 (Pubitemid 46376450)
259. Gloor JM, Winters JL, Cornell LD et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010;10:582-589
260. Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Hum Immunol 2010;71:268-273
261. Riethm\x81ller S, Ferrari-Lacraz S, M\x81ller MK et al. Donorspecific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation 2010;90:160-167
262. Tambur AR, Leventhal JR, Friedewald JJ, Ramon DS. The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation 2010;90:1117-1124
263. Taylor CJ, Kosmoliaptsis V, Sharples LD et al. Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation. Transplantation 2010;89:185-193
264. Futagawa Y, Terasaki PI. ABO incompatible kidney transplantation-an analysis of UNOS Registry data. Clin Transplant 2006;20:122-126 (Pubitemid 43349037)
265. Hurst FP, Sajjad I, Elster EA et al. Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience. Transplantation 2010;89:1396-1402
266. Takahashi K, Saito K, Takahara S et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004;4:1089-1096 (Pubitemid 38868599)
267. Tyden G, Donauer J, Wadstrom J et al. Implementation of a protocol for ABO-incompatible kidney transplantation-a three-center experience with 60 consecutive transplantations. Transplantation 2007;83:1153-1155 (Pubitemid 46743673)
268. Ishida H, Miyamoto N, Shirakawa H et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007;7:825-831 (Pubitemid 46481177)
269. Shimmura H, Tanabe K, Ishida H et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation 2005;80:985-988 (Pubitemid 41552897)
270. Norden G, Briggs D, Cockwell P et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006;13:148-153
271. Genberg H, Kumlien G, Wennberg L, Berg U, Tyden G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008;85:1745-1754
272. Genberg H, Kumlien G, Wennberg L, Tyden G. Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab. Transplantation 2007:84s-s47
273. Geyer M, Fischer KG, Drognitz O, Walz G, Pisarski P, Wilpert J. ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties. Contrib Nephrol 2009;162:47-60
274. Toki D, Ishida H, Setoguchi K et al. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009;9:567-577
275. Flint SM, Walker RG, Hogan C et al. Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. Am J Transplant 2011;11:1016-1024
276. Fuchinoue S, Ishii Y, Sawada T et al. The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation 2011;91:853-857
277. Wilpert J, Fischer K-G, Pisarski P et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transpl 2010;25:3778-3786
278. Kenmochi T, Saigo K, Maruyama M et al. Results of kidney transplantation from ABO-incompatible living donors in a single institution. Transplant Proc 2008;40:2289-2291
279. Gloor JM, Lager DJ, Fidler ME et al. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005;80:1572-1577 (Pubitemid 43005868)
280. Montgomery RA, Locke JE, King KE et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009;87:1246-1255
281. Segev DL, Simpkins CE, Warren DS et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005;5:2570-2575
282. Kaihara S, Okamoto M, Akioka K et al. Improved graft survival in ABO-incompatible living donor kidney transplantation. Transplant Proc 2005;37:1804-1805 (Pubitemid 40790837)
283. Schwartz J, Stegall MD, Kremers WK, Gloor J. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation 2006;82:155-163 (Pubitemid 44126808)
284. Shimmura H, Tanabe K, Tokumoto T et al. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation. Transplant Proc 2004;36:2172-2174 (Pubitemid 39424370)
285. Lipshutz GS, McGuire S, Zhu Q et al. ABO blood type-incompatible kidney transplantation and access to organs. Arch Surg 2011;146:453-458
286. Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 2012;367:2015-2025
287. Kumlien G, Ullstrom L, Losvall A, Persson LG, Tyden G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006;46:1568-1575 (Pubitemid 44326333)
288. Oettl T, Halter J, Bachmann A et al. ABO blood groupincompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transpl 2009;24:298-303
289. Montgomery RA, Locke JE. ABO-incompatible transplantation: less may be more. Transplantation 2007:84S-S9
290. Aikawa A, Ohara T, Arai K et al. Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clin Transpl 2004:135-142
291. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000;70:1331-1335
292. Winters JL, Gloor JM, Pineda AA, Stegall MD, Moore SB. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apheresis 2004;19:79-85 (Pubitemid 39006612)
293. Chikaraishi T, Sasaki H, Tsutsumi H et al. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. Transplant Proc 2008;40:3445-3447
294. Gloor J, Matas AJ. Steroid-free maintenance immunosuppression and ABO-incompatible transplantation. Transplantation 2010;89:648-649
295. Oettl T, Zuliani E, Gaspert A, Hopfer H, Dickenmann M, Fehr T. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation 2010;89:702-706
296. Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal retransplants-a second class mistake? Transplantation 1994;57:515-519 (Pubitemid 24075795)
297. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002;335-349
298. Cho YW, Cecka JM. Cadaver-donor renal retransplants. Clin Transpl 1993;469-484
299. Heise ER, Thacker LR, MacQueen JM, Peters TG. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation. Clin Transplant 1996;10:579-585 (Pubitemid 27010904)
300. Welsh KI, van DM, Bewick ME et al. Successful transplantation of kidneys bearing previously mismatched HLA A and B locus antigens. Transpl Int 1988;1:190-195
301. Farney AC, Matas AJ, Noreen HJ et al. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival? Clin Transplant 1996;10:147-156 (Pubitemid 26091823)
302. Mjörnstedt L, Konar J, Nyberg G, Olausson M, Sandberg L, Karlberg I. Renal retransplantation in patients with HLA-antibodies. Transpl Int 1992:5S-S34
303. Tufveson G, Bengtsson M, Bergström C et al. Is repeated mismatching at regrafting deleterious? Transpl Int 1992;5(Suppl. 1):S140-S142
304. Doxiadis II, de LP, D'Amaro J, de MJ, Schreuder GM, Claas FH. Repeated HLA mismatches in cadaveric renal transplantation: is it safe to transplant? Transplant Proc 1997;29:1408-1409 (Pubitemid 27126247)
305. Caskey FJ, Johnson RJ, Fuggle SV, Start S, Pugh D, Dudley CR Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome. Transplantation 2009;87:1727-1732
306. Alexander JW, Bennett LE, Breen TJ. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry. Transplantation 1994;57:871-876 (Pubitemid 24114680)
307. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005;294:2726-2733 (Pubitemid 41770102)
308. Chavalitdhamrong D, Gill J, Takemoto S et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation 2008;85:1573-1579
309. Johnson LB, Kno PC, Dafoe DC et al. Double adult renal allografts: a technique for expansion of the cadaveric kidney donor pool. Surgery 1996;120:580-584 (Pubitemid 26334309)
310. Remuzzi G, Grinyo J, Ruggenenti P et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol 1999;10:2591-2598
311. Schneider JR, Sutherland DE, Simmons RL, Fryd DS, Najarian JS. Long-term success with double pediatric cadaver donor renal transplants. Ann Surg 1983;197:439-442 (Pubitemid 13112786)
312. Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC. When should expanded criteria donor kidneys be used for single versus dual kidney transplants? Transplantation 1997;64:1142-1146 (Pubitemid 27467940)
313. Satterthwaite R, Aswad S, Sunga V et al. Outcome of en bloc and single kidney transplantation from very young cadaveric donors. Transplantation 1997;63:1405-1410 (Pubitemid 27237442)
314. Hobart MG, Modlin CS, Kapoor A et al. Transplantation of pediatric en bloc cadaver kidneys into adult recipients. Transplantation 1998;66:1689-1694 (Pubitemid 29034992)
315. Lee CM, Carter JT, Weinstein RJ et al. Dual kidney transplantation: older donors for older recipients. J Am Coll Surg 1999;189:82-82
316. Jerius JT, Taylor RJ, Murillo D, Leone JP. Double renal transplants from marginal donors: 2-year results. J Urol 2000;163:423-425 (Pubitemid 30060484)
317. Andres A, Morales JM, Herrero JC et al. Double versus single renal allografts from aged donors. Transplantation 2000;69:2060-2066 (Pubitemid 30395034)
318. Alfrey EJ, Boissy AR, Lerner SM, Dual KR. Dual-kidney transplants: long-term results. Transplantation 2003;75:1232-1236 (Pubitemid 36513026)
319. Bunnapradist S, Gritsch HA, Peng A, Jordan SC, Cho YW. Dual kidneys from
320. Sanchez-Fructuoso AI, Prats D, Perez-Contin MJ et al. Increasing the donor pool using en bloc pediatric kidneys for transplant. Transplantation 2003;76:1180-1184 (Pubitemid 37339641)
321. Tan JC, Alfrey EJ, Dafoe DC, Millan MT, Scandling JD. Dualkidney transplantation with organs from expanded criteria donors: a long-term follow-up. Transplantation 2004;78:692-696 (Pubitemid 39244730)
322. Rigotti P, Baldan N, Valente M et al. Evaluation of 84 elderly donors in renal transplantation. Clin Transplant 2004;18:440-445 (Pubitemid 39077080)
323. Palmes D, Wolters HH, Brockmann J, Senninger N, Spiegel HU, Dietl KH. Strategies for compensating for the declining numbers of cadaver donor kidney transplants. Nephrol Dial Transpl 2004;19:952-962 (Pubitemid 38455670)
324. Boggi U, Barsotti M, Collini A et al. Kidney transplantation from donors aged 65 years or more as single or dual grafts. Transplant Proc 2005;37:577-580 (Pubitemid 40590631)
325. Dharnidharka VR, Stevens G, Howard RJ. En-bloc kidney transplantation in the United states: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003. Am J Transplant 2005;5:1513-1517 (Pubitemid 40839446)
326. Pelletier SJ, Guidinger MK, Merion RM et al. Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant 2006;6:1646-1652 (Pubitemid 43945805)
327. Remuzzi G, Cravedi P, Perna A et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006;354:343-352 (Pubitemid 43145059)
328. Rigotti P, Ekser B, Furian L et al. Outcome of renal transplantation from very old donors. N Engl J Med 2009;360:1464-1465
329. Moore PS, Farney AC, Sundberg AK et al. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation 2007;83:1551-1556 (Pubitemid 46987905)
330. Mohanka R, Basu A, Shapiro R, Kayler LK. Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation 2008;86:264-268
331. Gill J, Cho YW, Danovitch GM et al. Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database. Transplantation 2008;85:62-68
332. Salifu MO, Norin AJ, O'Mahony C et al. Long-term outcomes of dual kidney transplantation-a single center experience. Clin Transplant 2009;23:400-406
333. Kayler LK, Magliocca J, Kim RD, Howard R, Schold JD. Single kidney transplantation from young pediatric donors in the United States. Am J Transplant 2009;9:2745-2751
334. Kayler LK, Mohanka R, Basu A, Shapiro R, Randhawa PS. Single versus dual renal transplantation from donors with significant arteriosclerosis on pre-implant biopsy. Clin Transplant 2009;23:525-531
335. Thomusch O, Tittelbach-Helmrich D, Meyer S, Drognitz O, Pisarski P. Twenty-year graft survival and graft function analysis by a matched pair study between pediatric en bloc kidney and deceased adult donors grafts. Transplantation 2009;88:920-925
336. Snanoudj R, Rabant M, Timsit MO et al. Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am J Transplant 2009;9:2542-2551
337. De Serres SA, Caumartin Y, Noel R et al. Dual-kidney transplants as an alternative for very marginal donors: long-term follow-up in 63 patients. Transplantation 2010;90:1125-1130
338. Bhayana S, Kuo YF, Madan P et al. Pediatric en bloc kidney transplantation to adult recipients: more than suboptimal? Transplantation 2010;90:248-254
339. Ratner LE, Cigarroa FG, Bender JS, Magnuson T, Kraus ES. Transplantation of single and paired pediatric kidneys into adult recipients. J Am Coll Surg 1997;185:437-445 (Pubitemid 27488570)
340. Ekser B, Furian L, Broggiato A et al. Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients. Am J Transplant 2010;10:2000-2007
341. O'Callaghan JM, Knight SR, Morgan RD, Morris PJ. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 2012;12:896-906
342. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12 (Pubitemid 26120810)
343. Wight J, Chilcott J, Holmes M, Brewer N. The clinical and costeffectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess 2003;7:1-94
344. Moers C, Smits JM, Maathuis MH et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009;360:7-19
345. Jochmans I, Moers C, Smits JM et al. Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg 2010;252:756-764
346. Watson CJ, Wells AC, Roberts RJ et al. Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial. Am J Transplant 2010;10:1991-1999
347. Opelz G, Dohler B. Multicenter analysis of kidney preservation. Transplantation 2007;83:247-253
348. Johnston TD, Thacker LR, Jeon H, Lucas BA, Ranjan D. Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004:18s-s32
349. Summers DM, Johnson RJ, Allen J et al. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet 2010;376:1303-1311
350. Hernandez D, Estupinan S, Perez G et al. Impact of cold ischemia time on renal allograft outcome using kidneys from young donors. Transpl Int 2008;21:955-962
351. Cecka JM. The OPTN/UNOS renal transplant registry. Clin Transpl 2004;1-16
352. Quiroga I, McShane P, Koo DDH et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transpl 2006;21:1689-1696 (Pubitemid 44063135)
353. Mikhalski D, Wissing KM, Ghisdal L et al. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008:85S-S9
354. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008;8:2062-2070
355. Narkun-Burgess DM, Nolan CR, Norman JE, Page WF, Miller PL, Meyer TW. Forty-five year follow-up after uninephrectomy. Kidney Int 1993;43:1110-1115 (Pubitemid 23137098)
356. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet 1992;340:807-810
357. Ibrahim HN, Foley R, Tan L et al. Long-term consequences of kidney donation. N Engl J Med 2009;360:459-469
358. Davis CL, Cooper M. The state of U. S. living kidney donors. Clin J Am Soc Nephrol 2010;5:1873-1880
359. Lentine KL, Schnitzler MA, Xiao H et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010;363:724-732
360. Segev DL, Muzaale AD, Caffo BS et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010;303:959-966
361. Young A, Storsley L, Garg AX et al. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant 2008;8:1878-1890
362. Textor SC, Taler SJ, Driscoll N et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004;78:276-282
363. Tent H, Sanders J-SF, Rook M et al. Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy. Transplantation 2012;93:412-417
364. Heimbach JK, Taler SJ, Prieto M et al. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 2005;5:1057-1064 (Pubitemid 40571254)
365. Mjoen G, Oyen O, Holdaas H, Midtvedt K, Line PD. Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry. Transplantation 2009;88:1273-1279
366. Tavakol MM, Vincenti FG, Assadi H et al. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephro 2009;4:1230-1238
367. Nogueira JM, Weir MR, Jacobs S et al. A study of renal outcomes in obese living kidney donors. Transplantation 2010;90:993-999
368. Torres VE, Offord KP, Anderson CF et al. Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int 1987;31:1383-1390 (Pubitemid 17090503)
369. Okamoto M, Suzuki T, Fujiki M et al. The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation 2010;89:1391-1395
370. Tsinalis D, Binet I, Steiger J, Gasser T, Thiel G. Can 'borderline' living kidney donors (BLKD) be used safely for transplantation? Kidney Blood Press Res 1999;22:388-390
371. Koselj M, Rott T, Kandus A, Vizjak A, Malovrh M. Donortransmitted IgA nephropathy: long-term follow-up of kidney donors and recipients. Transplant Proc 1997;29:3406-3407 (Pubitemid 28008527)
372. Koushik R, Garvey C, Manivel JC, Matas AJ, Kasiske BL. Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 2005;80:1425-1429 (Pubitemid 41803624)
373. Gross O, Weber M, Fries JWU, Muller G-A. Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol Dial Transpl 2009;24:1626-1630
374. Kido R, Shibagaki Y, Iwadoh K et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant 2010;10:1597-1604
375. Fauchald P, Sodal G, Albrechtsen D, Leivestad T, Berg KJ, Flatmark A. The use of elderly living donors in renal transplantation. Transpl Int 1991;4:51-53
376. Dols LFC, Weimar W, Ijzermans JNM. Long-term consequences of kidney donation. N Engl J Med 2009;360:2371-2372
377. Gracida C, Espinoza R, Cedillo U, Cancino J. Kidney transplantation with living donors: nine years of follow-up of 628 living donors. Transplant Proc 2003;35:946-947 (Pubitemid 36555240)
378. Ierino F, Boudville N, Kanellis J. The CARI guidelines. Donors at risk: hypertension. Nephrology 2010:15s-s120
379. Delmonico F. A Report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005:79s-s66
380. Isbel N. The CARI guidelines. Donors at risk: obesity. Nephrology 2010:15s-s132
381. Boudville N, Isbel N. The CARI guidelines. Donors at risk: impaired glucose tolerance. Nephrology 2010:15s-s136
382. Boudville N, Kanellis J. The CARI guidelines. Donors at risk: proteinuria. Nephrology 2010:15s-s110
383. Ierino F, Kanellis J. The CARI guidelines. Donors at risk: haematuria. Nephrology 2010:15s-s113
384. Cohney S, Kanellis J, Howell M, Cari. The CARI Guidelines. Donor renal function. Nephrology 2010:15s-s145
385. Grewal GS, Blake GM. Reference data for 51Cr-EDTA measurements of the glomerular filtration rate derived from live kidney donors. Nucl Med Commun 2005;26:61-65 (Pubitemid 40189626)
386. Cherikh WS, Young CJ, Kramer BF, Taranto SE, Randall HB, Fan PY Ethnic and gender related differences in the risk of endstage renal disease after living kidney donation. Am J Transplant 2011;11:1650-1655
387. Manas D, Burnapp L, Andrews PA, Bradley JA, Dudley C. United Kingdom Guidelines for Living Donor Kidney Transplantation. Chapter 5.5 Assessment of Renal Function. The Birtish Transplant Society; 2011. Retrieved from: www.bts.org.uk
388. Buszta C, Steinmuller DR, Novick AC et al. Pregnancy after donor nephrectomy. Transplantation 1985;40:651-654 (Pubitemid 16207192)
389. Ibrahim HN, Akkina SK, Leister E et al. Pregnancy outcomes after kidney donation. Am J Transplant 2009;9:825-834
390. Reisaeter AV, Roislien J, Henriksen T, Irgens LM, Hartmann A. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant 2009;9:820-824
391. Wrenshall LE, McHugh L, Felton P, Dunn DL, Matas AJ. Pregnancy after donor nephrectomy. Transplantation 1996;62:1934-1936 (Pubitemid 27014565)
392. Mackie F. The CARI guidelines. Potential child-bearing donors. Nephrology 2010:15s-s100
393. Cecka J. Living donor transplants. In: Cecka J, Terasaki P (eds). Clin Transpl Los Angeles. UCLA Tissue Typing Laboratory, 1995, pp. 263-277
394. Ratner LE, Hiller J, Sroka M et al. Laparoscopic live donor nephrectomy removes disincentives to live donation. Transplant Proc 1997;29:3402-3403 (Pubitemid 28008525)
395. Wilson CH, Sanni A, Rix DA, Soomro NA. Laparoscopic versus open nephrectomy for live kidney donors. Cochrane Database Syst Rev 2011 Issue 11. DOI: 10.1002/14651858. CD006124. pub2
396. Gibbons N, Nicol D. The CARI guidelines. Surgical techniques in living donor nephrectomy. Nephrology 2010;15:s88-s95
397. Kikic Z, Lorenz M, Sunder-Plassmann G et al. Effect of hemodialysis before transplant surgery on renal allograft function-a pair of randomized controlled trials. Transplantation 2009;88:1377-1385
398. Van Loo AA, Vanholder RC, Bernaert PR, Vermassen FE, Van dV, Lameire NH. Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol 1998;9:473-481 (Pubitemid 28122874)
399. Schmidt R, Kupin W, Dumler F, Venkat KK, Mozes M. Influence of the pretransplant hematocrit level on early graft function in primary cadaveric renal transplantation. Transplantation 1993;55:1034-1040 (Pubitemid 23150728)
400. Othman MM, Ismael AZ, Hammouda GE. The impact of timing of maximal crystalloid hydration on early graft function during kidney transplantation. Anesth Analg 2010;110:1440-1446
401. Bacchi G, Buscaroli A, Fusari M et al. The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience. Transplant Proc 2010;42:3387-3391
402. De Gasperi A, Narcisi S, Mazza E et al. Perioperative fluid management in kidney transplantation: is volume overload still mandatory for graft function? Transplant Proc 2006;38:807-809 (Pubitemid 44389513)
403. Ferris RL, Kittur DS, Wilasrusmee C, Shah G, Krause E, Ratner L. Early hemodynamic changes after renal transplantation: determinants of low central venous pressure in the recipients and correlation with acute renal dysfunction. Med Sci Monit 2003:9CR-CR66
404. O'Malley CM, Frumento RJ, Hardy MA et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005;100:1518-1524 (Pubitemid 40577418)
405. Hadimioglu N, Saadawy I, Saglam T, Ertug Z, Dinckan A. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008;107:264-269
406. Khajavi MR, Etezadi F, Moharari RS et al. Effects of normal saline vs. lactated ringer's during renal transplantation. Ren Fail 2008;30:535-539 (Pubitemid 351874066)
407. Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012;7. DOI: 10.1002/14651858. CD001319.pub5
408. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012;6. DOI: 10.1002/14651858. CD000567.pub5
409. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012;2:s1-s138
410. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transpl 2012, DOI: 10.1093/ndt/gfs375
411. Dalton RS, Webber JN, Cameron C et al. Physiologic impact of low-dose dopamine on renal function in the early post renal transplant period. Transplantation 2005;79:1561-1567 (Pubitemid 40847588)
412. McCune TR, Wombolt DG, Whelan TV, Thacker LR, Colonna JO. Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation. Int Immunopharmacol 2005;5:85-92 (Pubitemid 39626688)
413. Whelan TV, Chidester PD, Higgins MR, Connito DJ, Yeh BPY. Effect of postoperative low dose dopamine infusion on early renal allograft function [abstract]. J Am Soc Nephrol 1993;4:966
414. Chazot C, Lloveras JJ. Dopamine and fluid load prevent acute renal failure after kidney transplantation (abstract). Nephrol Dial Transpl 1987;2:460
415. Carmellini M, Romagnoli J, Giulianotti PC et al. Dopamine lowers the incidence of delayed graft function in transplanted kidney patients treated with cyclosporine A. Transplant Proc 1994;26:2626-2629 (Pubitemid 24329256)
416. Grundmann R, Kindler J, Meider G, St'we H, Sieberth HG, Pichlmaier H. Dopamine treatment of human cadaver kidney graft recipients: a prospectively randomized trial. Klin Wochenschr 1982;60:193-197 (Pubitemid 12171374)
417. O'Dair J, Evans L, Rigg KM, Shehata M. Routine use of renaldose dopamine during living donor nephrectomy has no beneficial effect to either donor or recipient. Transplant Proc 2005;37:637-639 (Pubitemid 40590653)
418. Ciapetti M, di Valvasone S, di Filippo A, Cecchi A, Bonizzoli M, Peris A. Low-dose dopamine in kidney transplantation. Transplant Proc 2009;41:4165-4168
419. Kadieva VS, Friedman L, Margolius LP, Jackson SA, Morrell DF. The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth Analg 1993;76:362-365 (Pubitemid 23085747)
420. Ferguson CJ, Hillis AN, Williams JD, Griffin PJ, Salaman JR. Calcium-channel blockers and other factors influencing delayed function in renal allografts. Nephrol Dial Transpl 1990;5:816-820 (Pubitemid 20373463)
421. Osman Y, Kamal M, Soliman S, Sheashaa H, Shokeir A, Shehab el-Dein AB. Necessity of routine postoperative heparinization in non-risky live-donor renal transplantation: results of a prospective randomized trial. Urology 2007;69:647-651 (Pubitemid 46574912)
422. Horvath JS, Tiller DJ, Duggin GG, McGrath BP, Montenegro R, Johnson JR. Low dose heparin and early kidney transplant function. Aust N Z J Med 1975;5:537-539
423. Lundin C, Bersztel A, Wahlberg J, Wadstrom J. Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation. Ups J Med Sci 2002;107:9-15
424. Mohan P, Murphy DM, Counihan A, Cunningham P, Hickey DP. The role of intraoperative heparin in cyclosporine treated cadaveric renal transplant recipients. J Urol 1999;162:682-684 (Pubitemid 29436848)
425. Murphy GJ, Taha R, Windmill DC, Metcalfe M, Nicholson ML. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation. Br J Surg 2001;88:261-266 (Pubitemid 32142716)
426. Nagra A, Trompeter RS, Fernando ON et al. The effect of heparin on graft thrombosis in pediatric renal allografts. Pediatr Nephrol 2004;19:531-535 (Pubitemid 38594292)
427. Robertson AJ, Nargund V, Gray DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renaltransplant recipients. Nephrol Dial Transpl 2000;15:1865-1868
428. Stechman MJ, Charlwood N, Gray DWR, Handa A. Administration of 75 mg of aspirin daily for 28 days is sufficient prophylaxis against renal transplant vein thrombosis. Phlebology 2007;22:83-85
429. Wilson CH, Bhatti AB, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2005;4. DOI: 10.1002/1465185
430. Fayek SA, Keenan J, Haririan A et al. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation 2012;93:304-308
431. Johnson CP, Kuhn EM, Hariharan S, Hartz AJ, Roza AM, Adams MB. Pre-transplant identification of risk factors that adversely affect length of stay and charges for renal transplantation. Clin Transplant 1999;13:168-176
432. Rabkin DG, Stifelman MD, Birkhoff J et al. Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc 1998;30:4314-4316 (Pubitemid 29013233)
433. Cole T, Hakim J, Shapiro R, Kayler LK. Early urethral (Foley) catheter removal positively affects length of stay after renal transplantation. Transplantation 2007;83:995-996 (Pubitemid 46682743)
434. Sorto R, Irizar SS, Delgadillo G, Alberu J, Correa-Rotter R, Morales-Buenrostro LE. Risk factors for urinary tract infections during the first year after kidney transplantation. Transplant Proc 2010;42:280-281
435. Glazer E, Akhavanheidari M, Benedict K, James S, Molmenti E. Cadaveric renal transplant recipients can safely tolerate removal of bladder catheters within 48h of transplant. Int J Angiol 2009;18:69-71
436. Kissel SM, Hoy WE, Freeman RB, Byer B, Yarger JM. Renal transplant urinary tract infections: effect of perioperative antibiotics and earlier catheter removal. N Y State J Med 1982;82:1543-1545 (Pubitemid 13206893)